These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Preliminary study and clinical evaluation method of ioversol in angiocardiography--establishment of safety evaluation parameters and reliability of radiographic quality evaluation]. Matsuyama S, Kuribayashi S, Ide M, Shigeta A, Umemura J, Harada J, Yamada T, Himi K, Takemoto A, Morimoto S. Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun 25; 50(6):620-36. PubMed ID: 2235313 [Abstract] [Full Text] [Related]
24. Iopamidol a new contrast agent in angiocardiography. Experimental and clinical experience in comparison with a commonly used contrast medium. Niccoli L, Bellandi M, Benedini G, Cucchini F, Ettori F, Leonzi O, Visioli O. Radiol Med; 1986 Jun 25; 72(6 Suppl 1):32-6. PubMed ID: 3726197 [No Abstract] [Full Text] [Related]
26. Addition of sodium to the nonionic contrast medium iohexol during coronary angiography in man. Lack of electrocardiographic or hemodynamic effects. Vik-Mo H, Bjørkhaug A, Danielsen R, Følling M, Kloster Y, Skinningsrud K. Acta Radiol; 1992 Sep 25; 33(5):485-9. PubMed ID: 1389661 [Abstract] [Full Text] [Related]
40. Phase II studies in urography, cardioangiography and cerebral angiography with iohexol. An evaluation of the clinical trial program and the clinical findings. Andrew E, Sveen K, Renaa T, Dahlstrøm K. Eur J Radiol; 1983 Aug 25; 3(3):194-201. PubMed ID: 6628397 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]